Business description
PolyPeptide Group is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
Management board & Supervisory board
| CEO |
| Juan José Gonzalez |
| Management board |
| Marc Augustin, Christina Del Vecchio, Jens Fricke |
| Supervisory board |
| Peter Wilden, Patrick Aebischer, Beat In-Albon, Jane Salik, Erik Schropp, Philippe A. Weber |
Company data
| Name: |
POLYPEPTIDE N |
| Address: |
Neuhofstrasse 24,Baar |
| Phone: |
+41 435 020 580 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.polypeptide.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
40.37% |
| IPO date: |
2021-04-29 |
